UNICHEMLAB NSE filing

Re-lodgement of Transfer Requests of Physical Shares

The RealCase readLow impact Neutral

Unichem Laboratories Limited received a report regarding the re-lodgement of transfer requests of physical shares for October 2025 from MUFG Intime India Private Limited, in compliance with SEBI guidelines.

Why it matters

The announcement is a routine update regarding share transfer requests and has a low impact on the company's operations or stock price.

The market read

The announcement is about the re-lodgement of physical shares and does not contain any positive or negative information.

* Unichem Laboratories Limited received the 4th report dated 17th November 2025 from their Registrar and Share Transfer Agent, MUFG Intime India Private Limited. * The report pertains to the re-lodgement of transfer requests of physical shares for the month ended 31st October 2025, as per SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated 2nd July 2025. * MUFG Intime India Private Limited confirms that during the month, they received NIL requests, processed NIL requests and approved NIL requests.

Filing to action

What to do with a filing like this

Unichem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Unichem Laboratories Limited. Read the original for the full detail.

View original filing